Accessibility Menu
Novo Nordisk logo

Novo Nordisk

(NYSE) NVO

Current Price$47.40
Market Cap$159.24B
Since IPO (1981)+41,129%
5 Year+28%
1 Year-29%
1 Month+5%

Novo Nordisk Financials at a Glance

Market Cap

$159.24B

Revenue (TTM)

DKK 327.80B

Net Income (TTM)

DKK 121.96B

EPS (TTM)

$4.26

P/E Ratio

11.12

Dividend

$1.80

Beta (Volatility)

0.70 (Low)

Price

$47.40

Volume

45,805.633

Open

$46.80

Previous Close

$47.42

Daily Range

$46.44 - $47.43

52-Week Range

$35.12 - $71.80

Estimated Earnings Date

Aug 5, 2026

About Novo Nordisk

Industry

Pharmaceuticals

Employees

68,794

CEO

Maziar Mike Doustdar

Headquarters

Bagsvaerd, 2880, DK

NVO Financials

Key Financial Metrics (TTM)

Gross Margin

81.85%

Operating Margin

45.30%

Net Income Margin

37.20%

Return on Equity

66.36%

Return on Capital

39.28%

Return on Assets

21.81%

Earnings Yield

8.99%

Dividend Yield

3.80%

Payout Ratio

42.47%

Stock Overview

Market Cap

$159.24B

Shares Outstanding

3.36B

Volume

45.81K

Avg. Volume

15.49M

Financials (TTM)

Gross Profit

DKK 268.30B

Operating Income

DKK 148.49B

EBITDA

DKK 185.82B

Operating Cash Flow

DKK 118.60B

Capital Expenditure

-DKK 87.57B

Free Cash Flow

DKK 31.03B

Cash & ST Invst.

DKK 21.63B

Total Debt

DKK 146.38B

Novo Nordisk Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

DKK 96.82B

+24.0%

Gross Profit

DKK 83.23B

+27.7%

Gross Margin

85.96%

N/A

Market Cap

$159.24B

N/A

Market Cap/Employee

$2.06M

N/A

Employees

77,406

N/A

Net Income

DKK 48.56B

+67.2%

EBITDA

DKK 69.21B

+50.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

DKK 21.63B

-48.0%

Total Debt

DKK 146.38B

+23.3%

Accounts Receivable

DKK 100.27B

+16.1%

Inventory

DKK 51.35B

+19.8%

Long Term Debt

DKK 119.17B

+23.7%

Short Term Debt

DKK 27.21B

+21.4%

Return on Assets

21.81%

N/A

Return on Invested Capital

44.45%

N/A

Free Cash Flow

DKK 12.05B

+20.4%

Operating Cash Flow

DKK 24.08B

-2.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ABTAbbott Laboratories
$90.53+3.07%
GILDGilead Sciences, Inc.
$125.05+0.14%
TMOThermo Fisher Scientific Inc.
$469.35+1.15%
PFEPfizer Inc.
$24.72-1.44%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.32-0.04%
AAPLApple
$294.83-0.01%
QBTSD-Wave Quantum
$25.10+0.03%
TSLATesla
$382.02-0.06%

Questions About NVO

What is the current price of Novo Nordisk?

Novo Nordisk is trading at $47.42 per share.

What is the 52-week range for Novo Nordisk?

Over the past 52 weeks, Novo Nordisk has traded between $35.12 and $71.80.

How much debt does Novo Nordisk have?

As of the most recent reporting period, Novo Nordisk reported total debt of DKK 22.57B.

How much cash does Novo Nordisk have on hand?

Novo Nordisk reported DKK 3.26B in cash and cash equivalents in its most recent financial results.

What is Novo Nordisk’s dividend yield?

Novo Nordisk currently has a dividend yield of 3.80%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.